"Integrated Chemotherapeutic Reprogramming and Targeted Senotherapeutic Clearance Elicits Near-Complete (80–89%) Restoration of Youthful Multi-Omic Profiles and Systemic Physiological Resilience."
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Integrated Chemotherapeutic Reprogramming and Targeted Senotherapeutic Clearance: A Transformative Anti-Aging Framework At the forefront of next-generation biomedical innovation, Nabinjyoti Behera, Founder of NAFVNA Pharmaceuticals, presents a groundbreaking and highly ambitious therapeutic paradigm designed to redefine the limits of human aging, systemic resilience, and cellular regeneration. Rooted in multidisciplinary expertise spanning Environmental Toxicology, Pharmaceutical Chemistry, and Mutation Virology, this research proposes a unified, whole-body rejuvenation system that moves beyond conventional anti-aging strategic
Fields of Study & Subjects
Telomeres
Telomerase
and Senescence
Genetics
Aging
and Longevity in Model Organisms
Pluripotent Stem Cells Research
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 28 March 2026
- Language
- EN